683 Capital Management is a hedge fund based in New York, founded in May 2006 by Ari Zweiman. The firm focuses on investing in late-stage biotechnology and healthcare companies, particularly in post-IPO equity and Series B and C funding.
Focus Areas
Investment Types
Notable Investments